Trials / Completed
CompletedNCT02431052
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris
A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 420 (actual)
- Sponsor
- Dermira, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objectives of this study are to assess the safety and efficacy DRM01 Topical Gel compared to vehicle in patients with acne vulgaris.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Olumacostat Glasaretil | |
| OTHER | Vehicle |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2016-04-01
- Completion
- 2016-04-01
- First posted
- 2015-04-30
- Last updated
- 2021-07-20
- Results posted
- 2019-02-26
Locations
34 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT02431052. Inclusion in this directory is not an endorsement.